Weekly Roundup: Moderna Rises, Dollar General Gains, Deckers Outdoor Sinks
On this episode of Stock Movers: - Moderna (MRNA), along with shares of other vaccine developers like Novavax (NVAX) rose this week after hearing the FDA's approach for the path forward on Covid shots. Moderna jumped as much as 15% on Tuesday after the FDA outlined guidance that was received as "better than expected", and may contain a silver lining, according to Bloomberg Intelligence analyst Sam Fazeli. “The guidance, coming from two critics of the booster program, may actually increase the uptake of shots in the general US population given many have co-morbidities,” Fazeli…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.